ConductScience.org, home

Paper36980941

How Genetic Variants in Children with Familial Hypercholesterolemia Not Only Guide Detection, but Also Treatment.

van den Bosch SE and 3 others. Genes (Basel), 2023. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. How Genetic Variants in Children with Familial Hypercholesterolemia Not Only Guide Detection, but Also Treatment. Papers, record 36980941. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36980941

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
How Genetic Variants in Children with Familial Hypercholesterolemia Not Only Guide Detection, but Also Treatment.
PubMed
Journal
Genes (Basel)
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
1.1
iCite
Revised in PubMed
2024-09-15
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1van den Bosch SESibbeliene Ehttps://orcid.org/0000-0001-9911-2456
2Corpeleijn WEWillemijn E
3Hutten BABarbara Ahttps://orcid.org/0000-0002-9243-0037
4Wiegman AAlberthttps://orcid.org/0000-0001-6223-5671

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cardiovascular DiseasesMajor topic
Homozygous Familial HypercholesterolemiaMajor topic
Hyperlipoproteinemia Type IIMajor topic
Humans
Child
Proprotein Convertase 9
Cholesterol, LDL
Carrier Proteins
Angiopoietin-Like Protein 3

Source PubMed

Download CSV of topics

References70

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135184975Intima-media thickness in treated and untreated patients with and without familial hypercholesterolemia: A systematic review and meta-analysis.J Clin Lipidol2022https://conductscience.org/library/papers/35184975PubMed
232609313Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia.JAMA Cardiol2020https://conductscience.org/library/papers/32609313PubMed
334971394Efficacy and safety of lomitapide in homozygous familial hypercholesterolaemia: the pan-European retrospective observational study.Eur J Prev Cardiol2022https://conductscience.org/library/papers/34971394PubMed
434506743Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC).Lancet2021https://conductscience.org/library/papers/34506743PubMed
534357325The Effect of Mipomersen in the Management of Patients with Familial Hypercholesterolemia: A Systematic Review and Meta-Analysis of Clinical Trials.J Cardiovasc Dev Dis2021https://conductscience.org/library/papers/34357325PubMed
630555131Liver Transplantation for Homozygous Familial Hypercholesterolemia.J Atheroscler Thromb2019https://conductscience.org/library/papers/30555131PubMed
732468833Prevalence of Familial Hypercholesterolemia Among the General Population and Patients With Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analysis.Circulation2020https://conductscience.org/library/papers/32468833PubMed
832331936PCSK9 inhibition with alirocumab in pediatric patients with heterozygous familial hypercholesterolemia: The ODYSSEY KIDS study.J Clin Lipidol2020https://conductscience.org/library/papers/32331936PubMed
935511818Screening in children for familial hypercholesterolaemia: start now.Eur Heart J2022https://conductscience.org/library/papers/35511818PubMed
1015070569Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia.Lancet2004https://conductscience.org/library/papers/15070569PubMed
1136047306Pharmacotherapy for children with elevated levels of lipoprotein(a): future directions.Expert Opin Pharmacother2022https://conductscience.org/library/papers/36047306PubMed
1232646561Efficacy and Safety of Alirocumab in Adults With Homozygous Familial Hypercholesterolemia: The ODYSSEY HoFH Trial.J Am Coll Cardiol2020https://conductscience.org/library/papers/32646561PubMed
1325053660
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society.
Eur Heart J2014https://conductscience.org/library/papers/25053660PubMed
147374711Plasma-exchange therapy of homozygous familial hypercholesterolemia.N Engl J Med1980https://conductscience.org/library/papers/7374711PubMed
1527998826Ideal cardiovascular health influences cardiovascular disease risk associated with high lipoprotein(a) levels and genotype: The EPIC-Norfolk prospective population study.Atherosclerosis2017https://conductscience.org/library/papers/27998826PubMed
1626009596Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment.Eur Heart J2015https://conductscience.org/library/papers/26009596PubMed
1724192652Carotid intima-media thickness in children with familial hypercholesterolemia.Circ Res2014https://conductscience.org/library/papers/24192652PubMed
1828538136Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease.N Engl J Med2017https://conductscience.org/library/papers/28538136PubMed
1935323699Insight into the Evolving Role of PCSK9.Metabolites2022https://conductscience.org/library/papers/35323699PubMed
203161854020-Year Follow-up of Statins in Children with Familial Hypercholesterolemia.N Engl J Med2019https://conductscience.org/library/papers/31618540PubMed

See all 70 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
42105138Artificial intelligence-driven rational design and optimization of a potent terpenoid-derived PCSK9 inhibitor.Mol Divers2026https://conductscience.org/library/papers/42105138PubMed
40399983Long noncoding RNAs in familial hypercholesterolemia: biomarkers, therapeutics, and AI in precision medicine.Lipids Health Dis2025https://conductscience.org/library/papers/40399983PubMed
38888644Familial hypercholesterolemia care by Dutch pediatricians-mind the gaps.Eur J Pediatr2024https://conductscience.org/library/papers/38888644PubMed
38540356Genetic Counseling and Genetic Testing for Familial Hypercholesterolemia.Genes (Basel)2024https://conductscience.org/library/papers/38540356PubMed
38188455CTCA in children with severe heterozygous familial hypercholesterolaemia: Screening for subclinical atherosclerosis.Atheroscler Plus2024https://conductscience.org/library/papers/38188455PubMed
37623860Appropriateness of Dyslipidemia Management Strategies in Post-Acute Coronary Syndrome: A 2023 Update.Metabolites2023https://conductscience.org/library/papers/37623860PubMed

Download CSV of cited by

Genes10

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36980941

GET https://conductscience.org/api/papers/v1/36980941/references?page=2